Placeholder

SHOWCASE FEATURE: E-Solutions: E-Solutions On The Move

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 2596. Categories: , .

Product Description

Findings from Kalorama Information’s recent report, Market for Mobile Medical Apps, valued the market for mobile medical apps at about $150 million in 2011. Despite accounting for just 1% to 2% of the entire market for mobile apps, Kalorama forecasts healthcare apps will post 25% market growth annually over the next five years, compared with 23% growth estimated for the standard apps market during…

Sidebars:
Survey respondents describe the interfaces among the ­different cloud-based platforms that they currently use

Experts
Melissa Elder
. Pharmaceutical Analyst, Kalorama Information, a publisher of market research ­spanning the biotechnology, ­diagnostics, healthcare, medical device, and pharmaceutical industries. For more ­information, visit kaloramainformation.com.
Bill Kelly. President and ­Co-Founder, BioInformatics LLC, a provider of custom market research for the life-sciences industry. For more information, visit gene2drug.com.
Andy Lee. Deputy Head of Clinical Sciences and Operations, Sanofi, a global healthcare company working to prevent and treat disease. For more information, visit sanofi.us.
Monique Levy.  VP of Research, ­Manhattan Research, a global ­pharmaceutical and healthcare market research and advisory firm focused on the digital trends shaping the future of consumer and physician marketing. For more information, visit manhattanresearch.com.
Greg Moody. Director, Clinical ­Informatics, Millennium: The Takeda ­Oncology Company, a biopharmaceutical company focused on improving the treatment of cancer worldwide. For more ­information, visit millennium.com.
Mary Myers. Director, Training & Development, Eisai Inc., a U.S.-based pharmaceutical subsidiary of Japan’s Eisai Co. Ltd. For more information, visit us.eisai.com.

FEEDBACK